Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa-infected patients.

@article{Judd2016ClinicalAE,
  title={Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa-infected patients.},
  author={William Judd and Patrick D. Ratliff and Ryan P. Hickson and Dana M Stephens and Charles A Kennedy},
  journal={American journal of infection control},
  year={2016},
  volume={44 11},
  pages={
          1275-1279
        }
}

• William Judd, Patrick D. Ratliff, +2 authors Charles A Kennedy
• Published 2016 in American journal of infection control
• DOI:10.1016/j.ajic.2016.04.218

BACKGROUND The emergence of carbapenem resistance has had a significant impact on both clinical and economic outcomes. METHODS A retrospective, observational cohort study was performed in a 433-bed tertiary care medical center. The cohort was established from all inpatients with Pseudomonas aeruginosa-positive cultures over a 3-year period. Two multivariate models were developed: a logistic regression model to evaluate the primary outcome of in-hospital mortality and a linear regression model… CONTINUE READING

Save to Library

Create Alert

Cite

View on PubMed